chr5-176906017-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001199298.2(UIMC1):āc.1943C>Gā(p.Ala648Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000026 in 1,614,008 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001199298.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
UIMC1 | NM_001199298.2 | c.1943C>G | p.Ala648Gly | missense_variant | 14/15 | ENST00000511320.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
UIMC1 | ENST00000511320.6 | c.1943C>G | p.Ala648Gly | missense_variant | 14/15 | 1 | NM_001199298.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 152174Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 251070Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135692
GnomAD4 exome AF: 0.0000137 AC: 20AN: 1461716Hom.: 0 Cov.: 30 AF XY: 0.0000138 AC XY: 10AN XY: 727170
GnomAD4 genome AF: 0.000144 AC: 22AN: 152292Hom.: 0 Cov.: 32 AF XY: 0.0000806 AC XY: 6AN XY: 74462
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 03, 2022 | The c.1943C>G (p.A648G) alteration is located in exon 14 (coding exon 13) of the UIMC1 gene. This alteration results from a C to G substitution at nucleotide position 1943, causing the alanine (A) at amino acid position 648 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at